Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jun 14, 2023

BUY
$1.1 - $2.45 $35,102 - $78,181
31,911 New
31,911 $39,000
Q4 2022

Feb 07, 2023

BUY
$1.1 - $2.45 $1,639 - $3,650
1,490 Added 4.9%
31,911 $40,000
Q2 2022

Aug 05, 2022

BUY
$2.27 - $4.86 $22 - $48
10 Added 0.03%
30,421 $84,000
Q4 2021

Feb 08, 2022

BUY
$5.37 - $7.07 $4,768 - $6,278
888 Added 3.01%
30,411 $168,000
Q2 2021

Aug 10, 2021

BUY
$7.78 - $11.4 $45,940 - $67,317
5,905 Added 25.0%
29,523 $251,000
Q2 2020

Aug 07, 2020

BUY
$1.58 - $4.63 $37,316 - $109,351
23,618 New
23,618 $109,000

Others Institutions Holding AFMD

About Affimed N.V.


  • Ticker AFMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 149,339,008
  • Market Cap $520M
  • Description
  • Affimed N.V., a clinical-stage biopharmaceutical company, focuses on discovering and developing cancer immunotherapies in the United States, Germany, and rest of Europe. Its lead product candidate is AFM13, which has completed Phase II clinical study for peripheral T-cell lymphoma; in Phase IIa clinical trial for CD30-positive lymphoma; and in P...
More about AFMD
Track This Portfolio

Track State Board Of Administration Of Florida Retirement System Portfolio

Follow State Board Of Administration Of Florida Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Board Of Administration Of Florida Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on State Board Of Administration Of Florida Retirement System with notifications on news.